GE unveils health tech company focusing on blood sample collection

GE launched Drawbridge Health, a privately held healthcare technology company that is developing proprietary technology to collect blood samples.

The technology aims to enable blood drawing, collection and sample stabilization in a single device. It also aims to allow for room temperature shipping and easy processing.

Lee McCracken will serve as Drawbridge Health CEO. He is equipped with more than 25 years of experience in the biotech, pharmaceuticals and diagnostics industries. He previously served as CEO of Gensignia Life Sciences, a molecular diagnostics company.

"The current sample testing process is inconvenient and challenging for patients and medical providers, alike," said Mr. McCracken. "It requires clinical processing equipment, often a technician specifically trained to draw blood, plus a trip to the doctor's office or hospital. By combining world class GE technology and a talented founding team to address an important market need, Drawbridge Health is well positioned to transform diagnostic testing for healthcare stakeholders, testing laboratories, patients and consumers."

More articles on health IT:
HHN names 1st non-US hospital to 'Most Wired' list
Viewpoint: The 'unicorn' test doesn't work for digital health startups
CMO for England: Genomics will shorten 'diagnostic odyssey' for patients with rare disease

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months